Correlation European Harm Reduction Network

16/07/2026

Behind prison walls, harm reduction is often out of reach — even when it's available just outside the gate.

We invite you to read a recently published article - Beyond the Prison Gate: Why Harm Reduction Belongs in Prison, written by our research and advocacy intern Matilde De Sousa, published on Talking Drugs. Drawing on 2025 monitoring data collected by C-EHRN, Matilde examines the current state of harm reduction services in prisons and why this setting deserves far greater attention.

Where evidence-based harm reduction services exist in the community, they should also exist in prisons - this is the principle of equivalence of care. Prison drug markets are also constantly evolving. Prison health responses need to evolve with them.

People in prison shouldn’t lose their right to health. Read the full article to see what the data shows, and why closing this gap matters. 🔗 https://buff.ly/dTQ9xAG

13/07/2026

We are proud to present the last mini report from the 2025 Monitoring series on Full Spectrum Harm Reduction.

In this report you will find:
- Specification of the barriers and risks faced by people who use drugs depending on their demographics
- A detailed view on integration efforts of harm reduction services, with regards to healthcare and work and employment
- The current state of peer involvement with recommendations for improving peer participation

Read more in the full report: https://correlation-net.org/2026/07/13/full-spectrum-harm-reduction-in-europe-specific-populations-service-integration-and-peer-involvement-civil-society-monitoring-of-harm-reduction-in-europe-2025/

This completes the 2025 launch of monitoring data. To see the aggregated data, we invite you to visit our dashboard:

https://correlation-net.org/2026/05/07/c-ehrn-monitoring-dashboard-2025/

We are also excited to announce that we are busy with this year's monitoring data collection, which we hope to start presenting to you this autumn!

26/06/2026

💚 Today, Correlation celebrates the Support. Don't Punish Global Day of Action!

We advocate for harm reduction, and human rights and health-centred drug policies. It's time to push back against harmful narratives and politics!


https://supportdontpunish.org

26/06/2026

Today, on the 2026 Support. Don’t Punish. Global Day of Action, we are releasing our latest mini report on Basic Harm Reduction in Europe.

Inside the report:

- Data on availability and accessibility of services including Opioid Agonist Treatment (OAT), needle and syringe exchange programmes, safer smoking kits and others
- Five-year trends in European harm reduction
- Evidence suggesting that services must evolve alongside emerging drug trends to provide better-suited care

The report’s findings and recommendations echo the Support. Don’t Punish message: a focus on public health, human rights and community-rooted harm reduction is a vital alternative to the "war on drugs".

Read the full report here: https://buff.ly/ITgo0YY

If you want to explore further, make sure to visit our dashboard for monitoring data 2025 here: https://buff.ly/uIj3ztO

25/06/2026

🇪🇺 EU-COMP Partners Meet in Lisbon to Advance Competency-Based Training Across Europe

🤝 On 18–19 June 2026, partners of the EU-COMP project gathered at the European Union Drugs Agency - EUDA headquarters in Lisbon for a two-day meeting dedicated to reviewing progress, sharing results, and planning the next phases of the project.

A key milestone was the presentation of the final results of Work Package 1 (WP1), which examined training needs and competency development among professionals working across the drugs field.

Find out more: https://buff.ly/tYBQJmC

23/06/2026

🇱🇺 Abrigado CNDS is a low-threshold centre providing harm reduction and mental health services in Luxembourg. It provides specialised support alongside traditional harm reduction services, including a women’s shelter, Marga. Recently, Abrigado CNDS became a new member of Correlation’s Focal Point Network.

To discuss Abrigado’s growing services and the motivations behind becoming a C-EHRN Focal Point, we interviewed Claudia Allar, the organisation’s manager.

🔗 Read the full interview here: https://buff.ly/fnO3A3T

18/06/2026

🚨 Open letter from civil society to European leaders: deliver a budget that is up to the challenge!

On June 18th and 19th, European leaders are meeting to discuss the next long-term EU budget (2028–2034), known as the Multiannual Financial Framework (MFF). The decisions they make will shape Europe's ability to respond to upcoming challenges.

This is why we have joined and signed Civil Society Europe’s open letter supporting the European Parliament’s position of a strong MFF, which devotes 1.27% of EU GNI to new investments, supported by adequate new resources.

The letter states that Europe needs a budget that:

✅ Supports regions, social cohesion and rural communities;
✅ Invests in research, skills and youth;
✅ Recognises culture and civil society as essential pillars of the European project;
✅ Allows the EU to remain a global reliable partner for sustainable development, human rights, and gender equality.

At the same time, the debate around the EU budget cannot be limited to national balances and contributions. There needs to be a serious discussion on European own resources that can provide the Union with sustainable and fair sources of revenue.

📝 Read the open letter here: https://bit.ly/4oDcUUK

Every signature shows commitment towards strengthening our message: Europe needs the means to reach its ambitions.

15/06/2026

(Part 2) Taking a closer look at one of the key findings from our 2025 Civil Society Monitoring report on New Drug Trends: substance-specific trends across Europe.

This year's data highlights shifts in patterns involving he**in, synthetic opioids, pregabalin, benzodiazepines, crack co***ne, ketamine, and synthetic cannabinoids — each with distinct implications for harm reduction services and coordinated response.

Explore the full New Drug Trends report here: https://buff.ly/Ugp5o9S

15/06/2026

(Part 1) Taking a closer look at one of the key findings from our 2025 Civil Society Monitoring report on New Drug Trends: substance-specific trends across Europe.

This year's data highlights shifts in patterns involving he**in, synthetic opioids, pregabalin, benzodiazepines, crack co***ne, ketamine, and synthetic cannabinoids — each with distinct implications for harm reduction services and coordinated response.

Explore the full New Drug Trends report here: https://buff.ly/Ugp5o9S

09/06/2026

💡New Study on “Recent Adverse Developments for Non-Governmental Organisations in Europe”

In February, the Expert Council on NGO Law published a study about the situation of NGOs in Europe in 2024-2025. Based on questionnaire responses from NGOs in 30 countries, the study discusses how anti-NGO policies and funding cuts have affected the sector and what organisations should do to tackle these challenges.

🔗 Read the study here:

The Council of Europe is the continent’s leading human rights organisation, bringing together governments to build a future based on human rights, democracy and justice.